Science Projects

Ec BirA is a new protein:DNA linking system and JCU's proof-of-concept application in quantitative immuno‑PCR (qIPCR). This technology can also be used to create bispecific antibodies.

Hepatocellular carcinoma (HCC) is associated with very poor survival and is a leading cause of cancer-related deaths. New and innovative therapies for HCC are urgently required.

Technology platform for vaccine design useful for multiple indications in infectious diseases, cancer, & autoimmunity. Proof of concept demonstrated with a potentially universal oral influenza vaccine candidate.

The screening platform identifies compounds that modulate dendritic cell function, for drug discovery in cancer immunotherapy, autoimmunity, allergies, infectious diseases & transplant rejection.

Poor wound healing after trauma, surgery, acute illness, or chronic disease conditions affects millions of people worldwide each year. It is critical to develop a better wound dressing material that can promote local tissue regeneration.

Malaria is a mosquito-borne parasitic infection caused by Plasmodia. There are five species that cause the disease, of which P. falciparum and P. vivax are considered the greatest threat. There is a global public health need for a vaccine.

Researchers have developed a low cost, easy to use fluorescence-based Zinc & Copper sensing reagent that can be deployed on a real-time thermal cycler.